UNSPSC 51392208: Indanidine

This classification denotes an alpha-adrenergic agonist with the molecular formula C11H13N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MP564IFE34, chemically known as 2h-indazol-4-amine, n-(4,5-dihydro-1h-imidazol-2-yl)-2-methyl-, hydrochloride but generally known as indanidine, which bears US NIH Compound Identifier 121924. European Medicines Agency schedules Indanidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08167MIG.

UNSPSC 51392208 Indanidine is a Commodity code that in practice covers pharmaceutical products and systems procured by state and local health and human services agencies, though recent activity shows limited direct solicitation under this specific code. The recent opportunities tagged to this code reflect a broader pattern of state and local procurement of naloxone and drug deactivation systems for community health and overdose-response programs, as well as exploratory activity around direct-to-manufacturer pharmaceutical supply relationships. Issuing bodies include county health departments and state health and human services commissions, with the scope of work ranging from emergency-response pharmaceutical inventory (naloxone) to infrastructure for controlled-substance deactivation and, at the state level, strategic pharmacy benefit program redesign through direct manufacturer engagement.

Recent activity centers in Florida and Texas. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries and a response deadline of July 26, 2023 (note: date inconsistency in source). The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 to gather vendor market intelligence on implementing a Therapeutic Pharmacy Initiative direct-to-manufacturer prescription program, signaling state-level interest in alternative pharmaceutical supply and pricing models outside traditional pharmacy benefit manager and group purchasing organization channels. The Seminole County procurement includes FEMA funding compliance requirements, E-Verify and drug-free workplace certifications, and a three-month probationary contract period; the Texas RFI is preliminary information-gathering with no formal award value or binding timeline specified at this stage.